2
POPSFDA Eyes Acetaminophen Liver Risk Three FDA advisory committees will hold a joint meeting on June 29 and 30 to discuss six options to further reduce the risk of liver injury from acetaminophen. Those options are: * Option 1: Reduce current doses or restrict the current maximum adult daily dose, single adult dose, and tablet strength to prescription only. * Option 2: Establish package-size limits for OTC acetaminophen products. * Option 3: Require unit-of-use packaging for prescription acetaminophen products. That means that the products will come to the pharmacy packaged ready for sale, with standardized labeling, instead of in bulk containers. * Option 4: Expand the product warning information on prescription acetaminophen products. For instance, the FDA might require "acetaminophen" to be on the ingredient list, instead of being listed as "APAP," so that consumers can identify that the drug contains acetaminophen. * Option 5: Eliminate combination OTC and/or prescription products tha
1
Pops
Newest Clips
Latest Comments
Most Pops
Print
Save
Turn on live update